CureDuchenne
cureduchenne.org Direct investor
CureDuchenne is a nonprofit organization that funds research toward treatments and a cure for Duchenne muscular dystrophy through a venture philanthropy model. It also runs care, education and family support programs.
CureDuchenne is an investor headquartered in Newport Beach, United States. It invests directly in companies, in duchenne muscular dystrophy, biotech and gene therapy.
“We will fulfill our mission to cure Duchenne muscular dystrophy with our innovative venture philanthropy model that funds groundbreaking research, early diagnosis and treatment access.”
— CureDuchenne, own website
- Layer
- Direct investor
- Type
- Other
- Stage
- Not stated
- Headquarters
- Newport Beach, United States
- Sectors
- Duchenne muscular dystrophy, biotech, gene therapy
Team, as CureDuchenne publishes it
- Debra Miller Founder & CEO
Names and roles exactly as listed on cureduchenne.org. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page CureDuchenne publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://cureduchenne.org/is_investor, type, hq_country, hq_city, sectors, thesis_quote, description, people, status
- https://cureduchenne.org/about/who-we-are/layer
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 16019 · added 2026-10-21 · link last verified 2026-10-21 · confidence medium
Similar investors
- Auctus Global CapitalOther · Growth – Buyout · Newport Beach, United States
- Checkmate CapitalOther · Pasadena, United States
- Cobro Ventures Management, LLCOther · Seed · McLean, United States
- Ishara Investments LPOther · Not applicable · Los Angeles, United States
- Research Corporation TechnologiesOther · Seed · Tucson, United States
- Sirocco Partners, LLCOther · Not applicable · Newport Beach, United States